INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.
Subscribe to see INVO Fertility, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
INVO Fertility, Inc. is a medical devices company headquartered in Sarasota, United States. It is publicly listed (IVF) with a market capitalisation of $3.4M. Xcout tracks 8 named people at INVO Fertility, Inc., including Steven Shum (Chief Executive Officer & Director).
2 more named people on record for INVO Fertility, Inc., with roles, board committees and tenure — see the full roster →
A few of INVO Fertility, Inc.'s closest competitors — see the full list of competitors and alternatives →
Founded in 2014 and headquartered in Richmond, Australia, Monash IVF Group Limited delivers specialized reproductive assistance and women's imaging services. Its operations span Australia and Malaysia, offering a broad spectrum of care. This includes diagnostic obstetric and gynecological ultrasound examinations, a range of fertility treatments, and advanced tertiary-level prenatal diagnostics. The company is also a key provider of in-vitro fertilization (IVF) services.
Vitrolife AB (publ) is a medical technology firm focused on the development, production, and commercialization of a wide array of products for assisted reproductive procedures. Its extensive product range encompasses specialized instruments such as oocyte retrieval needles and micromanipulation pipettes, alongside crucial consumables like sperm processing solutions, IVF culture media and oil, general labware, incubators, cryopreservation materials, and offerings for preimplantation genetic testing. Furthermore, the company supplies sophisticated technological platforms, including the EmbryoScope and Primo Vision time-lapse embryo monitoring systems, complete with compatible dishes and analytical tools. Other advanced solutions include Octax laser and imaging systems, as well as environmental control devices like log and guard systems and wireless sensors. Vitrolife maintains a significant global presence, with operations spanning Europe, the Middle East, Africa, Asia, the Japan and Pacific regions, and both North and South America. The company, headquartered in Gothenburg, Sweden, was established in 1994, originally operating under the name Scandinavian IVF Science before adopting its current identity as Vitrolife AB (publ) in 1998.
Vitrolife Group is a biotechnology research and medical device organization headquartered in Västra Frölunda, Sweden, specializing in reproductive health solutions through various global affiliates.
Gynesonics, Inc. is a U.S. medical-device company that develops minimally invasive, incision-free treatments for uterine fibroids. Its Sonata System uses transcervical radiofrequency ablation with intrauterine ultrasound guidance and serves gynecologists and women seeking fibroid treatment.
The Cooper Companies, Inc. is a global medical-device company with two main businesses: CooperVision, which develops and sells contact lenses, and CooperSurgical, which provides products and services for women’s health, fertility, and obstetric care. It serves eye-care professionals, patients, and healthcare providers worldwide.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.